Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Terlipressin vs Carbetocin in Open Myomectomy
NCT05266534Recruiting
- Sponsor
- Wael Elbanna Clinic
- Start
- Dec 2021
- Primary completion
- Jun 2024
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of terlipressin and carbetocin in uterine leiomyoma (3 arms), sponsored by Wael Elbanna Clinic. Primary endpoint: Volume of intraoperative blood loss at 12 hours. Started Dec 2021; status: recruiting.
02
Drugs
terlipressincarbetocin
03
Conditions
uterine leiomyoma
Beyond the preview
Go deeper on NCT05266534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05266534.